Facilitating Innovative Nuclear Diagnostics Act of 2021
Summary
Facilitating Innovative Nuclear Diagnostics Act of 2021 This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.
Bill status
in committee
1 of 4 stages cleared
Introduction
Aug 2021
Committee Review
Floor Vote
President
Introduced Aug 4, 2021
Last action Aug 4, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Aug 4, 2021
Committee
Read twice and referred to the Committee on Finance.
upper
Aug 4, 2021
Introduced
Introduced in Senate
upper
1 primary · 5 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2609
Scope: US
Hi! I can help you understand S 2609. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline